Clobenpropit: Difference between revisions
Content deleted Content added
fixed |
|||
Line 21: | Line 21: | ||
'''Clobenpropit''' is a [[histamine]] [[H3 antagonist|H<sub>3</sub> receptor]] [[receptor antagonist|antagonist]].<ref name="pmid17537431">{{cite journal |author=Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P |title=The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes |journal=Eur. J. Pharmacol. |volume=567 |issue=3 |pages=206–10 |year=2007 |pmid=17537431 |doi=10.1016/j.ejphar.2007.04.032}}</ref> It has [[neuroprotective]] effects via stimulation of [[GABA]] release in the brain.<ref>Dai H, Fu Q, Shen Y, Hu W, Zhang Z, Timmerman H, Leurs R, Chen Z. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons. ''European Journal of Pharmacology''. 2007 Jun 1;563(1-3):117-23. PMID 17350613</ref> |
'''Clobenpropit''' is a [[histamine]] [[H3 antagonist|H<sub>3</sub> receptor]] [[receptor antagonist|antagonist]].<ref name="pmid17537431">{{cite journal |author=Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P |title=The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes |journal=Eur. J. Pharmacol. |volume=567 |issue=3 |pages=206–10 |year=2007 |pmid=17537431 |doi=10.1016/j.ejphar.2007.04.032}}</ref> It has [[neuroprotective]] effects via stimulation of [[GABA]] release in the brain.<ref>Dai H, Fu Q, Shen Y, Hu W, Zhang Z, Timmerman H, Leurs R, Chen Z. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons. ''European Journal of Pharmacology''. 2007 Jun 1;563(1-3):117-23. PMID 17350613</ref> |
||
see the link below for the correct structure, please note the substitute is at 4-position, not at 2-position. |
|||
http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2790 |
|||
== See also == |
== See also == |
Revision as of 16:14, 19 October 2010
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H17ClN4S |
Molar mass | 308.83 g/mol g·mol−1 |
3D model (JSmol) | |
|
Clobenpropit is a histamine H3 receptor antagonist.[1] It has neuroprotective effects via stimulation of GABA release in the brain.[2]
See also
References
- ^ Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P (2007). "The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes". Eur. J. Pharmacol. 567 (3): 206–10. doi:10.1016/j.ejphar.2007.04.032. PMID 17537431.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Dai H, Fu Q, Shen Y, Hu W, Zhang Z, Timmerman H, Leurs R, Chen Z. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons. European Journal of Pharmacology. 2007 Jun 1;563(1-3):117-23. PMID 17350613